MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström’s macroglobulinemia
出版年份 2013 全文链接
标题
MYD88 L265P is a marker highly characteristic of, but not restricted to, Waldenström’s macroglobulinemia
作者
关键词
-
出版物
LEUKEMIA
Volume 27, Issue 8, Pages 1722-1728
出版商
Springer Nature
发表日期
2013-02-28
DOI
10.1038/leu.2013.62
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Response assessment in Waldenström macroglobulinaemia: update from the VIth International Workshop
- (2012) Roger G. Owen et al. BRITISH JOURNAL OF HAEMATOLOGY
- Development of high-resolution melting analysis for the detection of the MYD88 L265P mutation
- (2012) Cui-Zhu Wang et al. CLINICAL BIOCHEMISTRY
- Recurrent Mutations of MYD88 and TBL1XR1 in Primary Central Nervous System Lymphomas
- (2012) A. Gonzalez-Aguilar et al. CLINICAL CANCER RESEARCH
- Post-Treatment Bone Marrow Residual Disease > 5% by Flow Cytometry Is Highly Predictive of Short Progression-Free and Overall Survival in Patients With Waldenström's Macroglobulinemia
- (2012) R García-Sanz et al. Clinical Lymphoma Myeloma & Leukemia
- Differential Diagnosis of IgM MGUS and WM According to B-Lymphoid Infiltration by Morphology and Flow Cytometry
- (2012) Enrique M. Ocio et al. Clinical Lymphoma Myeloma & Leukemia
- Molecular pathogenesis of Waldenstrom's macroglobulinemia
- (2012) E. Braggio et al. HAEMATOLOGICA
- MYD88 Somatic Mutation Is a Genetic Feature of Primary Cutaneous Diffuse Large B-Cell Lymphoma, Leg Type
- (2012) Anne Pham-Ledard et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- IGHV gene features and MYD88 L265P mutation separate the three marginal zone lymphoma entities and Waldenström macroglobulinemia/lymphoplasmacytic lymphomas
- (2012) N Gachard et al. LEUKEMIA
- EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes
- (2012) J J M van Dongen et al. LEUKEMIA
- MYD88 L265P Somatic Mutation in IgM MGUS
- (2012) NEW ENGLAND JOURNAL OF MEDICINE
- MYD88 L265P Somatic Mutation in Waldenström's Macroglobulinemia
- (2012) Steven P. Treon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing
- (2012) J. G. Lohr et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Activating L265P mutations of the MYD88 gene are common in primary central nervous system lymphoma
- (2011) Manuel Montesinos-Rongen et al. ACTA NEUROPATHOLOGICA
- The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications
- (2011) E. Campo et al. BLOOD
- Absence of MYD88 gene mutation in acute leukemias and multiple myelomas
- (2011) Eun M. Je et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia
- (2011) Xose S. Puente et al. NATURE
- Analysis of the coding genome of diffuse large B-cell lymphoma
- (2011) Laura Pasqualucci et al. NATURE GENETICS
- Multiple Myeloma
- (2011) Antonio Palumbo et al. NEW ENGLAND JOURNAL OF MEDICINE
- Oncogenically active MYD88 mutations in human lymphoma
- (2010) Vu N. Ngo et al. NATURE
- How I treat Waldenstrom macroglobulinemia
- (2009) S. P. Treon BLOOD
- Multiparameter flow cytometry quantification of bone marrow plasma cells at diagnosis provides more prognostic information than morphological assessment in myeloma patients
- (2009) B. Paiva et al. HAEMATOLOGICA
- A probabilistic approach for the evaluation of minimal residual disease by multiparameter flow cytometry in leukemic B-cell chronic lymphoproliferative disorders
- (2008) C.E. Pedreira et al. CYTOMETRY PART A
- Report of the European Myeloma Network on multiparametric flow cytometry in multiple myeloma and related disorders
- (2008) A. C. Rawstron et al. HAEMATOLOGICA
- The incidence and survival of Waldenström's Macroglobulinaemia in South East England
- (2007) K.J. Phekoo et al. LEUKEMIA RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More